Pharmacokinetics and subjective effects of a novel oral LSD formulation in healthy subjects
OrthoEvidence Journal (OE Journal) - ACE Report
OE Journal. 2022;10(12):65 Br J Clin Pharmacol. 2019 23-Feb;():. 10.1111/bcp.13918What this means for my practice?
The present study confirmed previous findings that suggest a close relationship between LSD concentrations and LSD effects over time. This pharmacokinetic data for a novel oral LSD formulation may be useful for interpreting the findings of clinical studies and LSD intoxications. A study limitation was that the comparisons to LSD capsules used data from different studies that included different subjects, which may have contributed to the pharmacokinetic differences of the two LSD formulations.
Study Summary
Twenty-seven healthy participants were included in this placebo‐controlled, double‐blind, cross‐over study which aimed to characterize the pharmacokinetics and exposure–subjective response relationship of a novel oral solution of lysergic acid diethylamide (LSD). Participants were assigned to complete four experimental 12‐hour test sessions (100 μg LSD, 125 mg methylenedioxymethamphetamine [MDMA], 40 mg D‐amphetamine and placebo) with a washout period of at least 7 days between sessions. Only LSD and placebo data are presented in this study. LSD, O‐H‐LSD, nor‐LSD and iso‐LSD blood plasma concentrations were analysed by ultra‐high‐performance liquid chromatography tandem mass spectrometry and subjective drug effects were measured on a visual analogue scale. First‐order elimination kinetics were observed for LSD. The subjective effects of LSD were closely associated with changes in plasma concentrations over time.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
Are you affiliated with one of our partner associations?
Click here to gain complimentary access as part your association member benefits!